TrialCancer chemotherapy and pharmacology2024

Effect of food on the pharmacokinetics and safety profiles of a new PARP inhibitor fuzuloparib capsules in healthy volunteers.

Pengfei Du et al.PubMed ↗Publisher ↗

No numbers read from the abstract.